Generex Biotechnology Corporation is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist device.
Type | Public | |
HQ | Burlington, CA | Map |
Website | generex.com |
USD | |
---|---|
Revenue (Q3, 2020) | 498.7k |
Gross profit (Q3, 2020) | 382.4k |
Gross profit margin (Q3, 2020), % | 76.7% |
Net income (Q3, 2020) | (5.8m) |
EBIT (Q3, 2020) | (3.6m) |
Market capitalization (26-Feb-2021) | 47.3m |
Closing stock price (26-Feb-2021) | 0.4 |
Cash (30-Apr-2020) | 416.6k |
EV | 59.4m |
USD | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q3, 2013 | Q2, 2014 | Q3, 2014 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 9.9k | 5.0k | 7.0k | 2.2k | 700.0k | 1.7m | 3.4m | 1.1m | 721.7k | 498.7k | |||||||||||
Cost of goods sold | 3.3k | 3.6k | 2.2k | 870.6k | 2.0m | 1.3m | 133.6k | 116.3k | |||||||||||||
Gross profit | 6.7k | 1.3k | 4.8k | 848.5k | 1.4m | (172.0k) | 588.0k | 382.4k | |||||||||||||
Gross profit Margin, % | 67% | 27% | 68% | 49% | 42% | (16%) | 81% | 77% |
USD | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q2, 2014 | Q3, 2014 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 1.1m | 544.8k | 1.2m | 37.0k | 1.1m | 406.6k | 3.1m | 4.2m | 1.6m | 925.9k | 52.4k | 31.8k | 47.2k | 37.1k | 2.3m | 2.0m | 1.6m | 2.4m | 2.4m | 1.4m | 540.3k | 269.1k | 416.6k |
Accounts Receivable | 1.7k | 175.0 | 175.0 | 3.0m | 2.3m | 1.8m | 154.6k | 239.9k | 142.0k | ||||||||||||||
Prepaid Expenses | 193.6k | 1.5m | 296.3k | 116.3k | 187.3k | 68.5k | 102.4k | 45.5k | 99.8k | 49.0k | 52.0k | 5.2k | 8.1k | 11.1k | 293.3k | 227.0k | 161.7k | 193.2k | 286.4k | 218.8k | 451.3k | ||
Inventories | 500.6k | 500.6k | 22.7k | 12.0k | 12.0k | 12.0k | 838.7k | 1.1m | 250.0k | 727.3k | 861.1k | 911.0k |
USD | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q2, 2014 | Q3, 2014 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 336.4k | (8.8m) | (7.9m) | (656.2k) | (6.3m) | (5.0m) | (2.7m) | 270.9k | (462.3k) | (1.9m) | (1.7m) | (1.8m) | (860.3k) | (64.4m) | 27.5m | 17.7m | 21.1m | 17.8m | 5.4m | (5.8m) | (9.3m) | (16.6m) | (22.4m) |
Depreciation and Amortization | 163.7k | 320.1k | 472.1k | 117.0k | 234.6k | 349.0k | 191.8k | 203.4k | 291.4k | 52.7k | 123.1k | 194.2k | 2.3k | 1.2k | 2.0k | 17.5k | 25.7k | 378.2k | 550.3k | 203.3k | 407.1k | 609.0k | |
Inventories | 216.0k | 215.8k | 716.4k | 1.6k | 2.0k | 2.0k | 2.0k | (242.2k) | (386.0k) | (1.2m) | (98.2k) | (232.0k) | (281.9k) | ||||||||||
Accounts Payable | (13.9k) | (617.8k) | (1.3m) | 560.0k | 449.8k | 212.6k | 51.7k | (449.9k) | (378.3k) | 522.1k | 662.8k | 823.7k | 592.6k | 318.0k | 211.7k | 673.9k | 1.0m | 3.3m | 7.1m | 2.4m | 4.1m | 6.1m |
USD | Q1, 2012 |
---|---|
Debt/Equity | -0.3 x |
Debt/Assets | 0.3 x |
Financial Leverage | -1.1 x |
Generex Biotechnology has 782 Twitter Followers. The number of followers has increased 2.2% month over month and increased 8.8% quarter over quarter
609
Tweets
239
Following
782
Followers
2
Tweets last 30 days
5
Avg. likes per Tweet
100%
Tweets with engagement
Who are Generex Biotechnology key executives?
Generex Biotechnology's key executives are Joseph Moscato, Terry Thompson and Andrew Ro.
How many employees does Generex Biotechnology have?
Generex Biotechnology has 9 employees.
What is Generex Biotechnology revenue?
Latest Generex Biotechnology annual revenue is $6.2 m.
What is Generex Biotechnology revenue per employee?
Latest Generex Biotechnology revenue per employee is $689.3 k.
Who are Generex Biotechnology competitors?
Competitors of Generex Biotechnology include RespireRx Pharmaceuticals, Akorn and CASI Pharmaceuticals.
Where is Generex Biotechnology headquarters?
Generex Biotechnology headquarters is located at 4145 N Service Rd, Burlington.
Where are Generex Biotechnology offices?
Generex Biotechnology has offices in Burlington and Miramar.
How many offices does Generex Biotechnology have?
Generex Biotechnology has 2 offices.
Receive alerts for 300+ data fields across thousands of companies